Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-15

Study Completion Date

2026-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study, titled "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," aims to assess the long-term effectiveness of treatments for pediatric hip conditions, including hip dysplasia, Legg-Calve-Perthes disease, SCFE, and avascular necrosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Trial of Concomitant Hip Arthroscopy During PAO

NCT03181048

Hip Dysplasia

RECRUITING NA

Mild Hip Dysplasia

NCT03530878

Hip Dysplasia

WITHDRAWN NA

Periacetabular Osteotomy With Versus Without Adjunctive Hip Arthroscopy

NCT02790749

Hip Dysplasia

UNKNOWN NA

Education and Exercise for Patients With Longstanding Hip and Groin Pain

NCT05853640

Hip Pain Chronic Femoro Acetabular Impingement Groin Injury

RECRUITING NA

Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia

NCT06512506

Developmental Dysplasia of the Hip

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conducted at Mayo Clinic, the study combines retrospective chart reviews and prospective follow-up to gather data on clinical outcomes, radiographic measures, and patient-reported outcomes (PROs) like functional status, pain, and quality of life.

The retrospective component analyzes records from 1975 to 2024, while the prospective component includes follow-up surveys using validated PRO measures (e.g., HOOS, SF-12, VAS). This study seeks to identify recurrence rates and complications associated with hip treatments, providing insights to improve future care standards for pediatric hip conditions. Data will be securely stored, with confidentiality maintained throughout.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Dysplasia Legg-Calvâe-Perthes Disease Avascular Necrosis of Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pediatric patients with hip conditions

Medical records and radiographs of patients who were treated for hip conditions at Mayo Clinic from 1975 to 2022 will be included in a retrospective chart review. Radiographic evaluations will include measurements of the neck-shaft angle, acetabular index, migration index, and other commonly used metrics.

The prospective follow-up will include a subset of patients from the retrospective review, who will be complete long-term follow-up surveys.

Long-term Follow-up Surveys

Intervention Type OTHER

Patients will be given surveys, including validated PRO measures such as the Hip Disability and Osteoarthritis Outcomes Score (HOOS), Short-Form 12 (SF-12), Visual Analog Scale (VAS) for pain, and Marx activity scores.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Long-term Follow-up Surveys

Patients will be given surveys, including validated PRO measures such as the Hip Disability and Osteoarthritis Outcomes Score (HOOS), Short-Form 12 (SF-12), Visual Analog Scale (VAS) for pain, and Marx activity scores.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024
* Patients over 18 who can be contacted for follow-up and are willing to participate.